|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Market: Ukraine
Espicom Business Intelligence Ltd, Jan 2010, Pages: 38
This in-depth pharmaceutical market report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Executive Summary
Ukraine is the second largest country in Europe and the 22nd largest in the world. The population is estimated at 45.5 million in 2010. Ukraine aspires to join the EU, but currently Brussels will only consider negotiating agreements on free trade and visa facilitation. Relations with Russia remain complex, although they may improve if the pro-Russian candidates Viktor Yanukovich or Yulia Tymoshenko win the presidential election in early 2010, as seems likely.
Healthcare funding in Ukraine is largely through taxation. However, a system of public healthcare insurance has been under discussion since at least 1996. Government health expenditure is very low, even by Eastern European standards. Ukraine spends around 7.0% of GDP on healthcare, which is one of the lowest levels in Europe. Healthcare should be free for the whole population, but due to a lack of funding, patients are usually forced to make under-the-table payments.
Around 72% of the pharmaceutical market is supplied by imports. Germany and India were the leading suppliers in 2006, accounting for over 30% of imports. Foreign companies dominate the market in value terms, as domestic producers focus on the production of low-priced generics.
In 2008, the USTR lowered Ukraine from its Priority Watch List, to the standard Watch List, due to improvements in IPR protection. In 2006, Ukraine amended its Law on Medicines to provide protection against unfair commercial use of pharmaceutical data submitted in the marketing approval process. IPR protection was strengthened as part of Ukraine’s bid to gain entry to the WTO; the country became a member in May 2008.
A small number of companies have updated their facilities to comply with GMP standards. The government changed the deadline for GMP compliance from 2002 to 2007, but full adaptation is not expected until 2011.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data, and healthcare personnel.
Customers who bought this item also bought
The Pharmaceutical Market: Argentina
Indian Pharmaceutical Industry: Issues and Opportunities
|
|
|
|
